Predicting Malignant Mesothelioma by Analyzing Serum N-ERC/Mesothelin, C-ERC/Mesothelin, Hyaluronan, Osteopontin, and Syndecan-1 Levels


Arslan S., Mundt F., METİNTAŞ S. , AK G. , Dobra K., Hjerpe A., ...More

EURASIAN JOURNAL OF PULMONOLOGY, vol.19, no.3, pp.130-138, 2017 (Journal Indexed in ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 19 Issue: 3
  • Publication Date: 2017
  • Doi Number: 10.5152/ejp.2017.50023
  • Title of Journal : EURASIAN JOURNAL OF PULMONOLOGY
  • Page Numbers: pp.130-138

Abstract

Objective: Tumor biomarkers are promising study areas for the early or differential diagnosis of malignant pleural mesothelioma (MPM). This study aimed to determine the effectiveness of analyzing serum N-ERC/mesothelin, C-ERC/mesothelin, hyaluronan, osteopontin, and syndecan-1 levels for distinguishing patients with MPM from those with metastatic malignant pleural diseases (MMPDs), benign pleural diseases (BPDs), and benign asbestos pleurisy (BAP).